DK2235002T3 - 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer - Google Patents
4-pyridinonforbindelser og anvendelse heraf til behandling af cancerInfo
- Publication number
- DK2235002T3 DK2235002T3 DK09704457.2T DK09704457T DK2235002T3 DK 2235002 T3 DK2235002 T3 DK 2235002T3 DK 09704457 T DK09704457 T DK 09704457T DK 2235002 T3 DK2235002 T3 DK 2235002T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- treatment
- pyridinone compounds
- pyridinone
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2284808P | 2008-01-23 | 2008-01-23 | |
| PCT/US2009/031649 WO2009094417A1 (en) | 2008-01-23 | 2009-01-22 | 4-pyridinone compounds and their use for cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2235002T3 true DK2235002T3 (da) | 2013-03-11 |
Family
ID=40637826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09704457.2T DK2235002T3 (da) | 2008-01-23 | 2009-01-22 | 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8124768B2 (da) |
| EP (1) | EP2235002B1 (da) |
| JP (1) | JP5314050B2 (da) |
| KR (1) | KR101596527B1 (da) |
| CN (1) | CN101977906B (da) |
| AU (1) | AU2009206440B2 (da) |
| BR (1) | BRPI0906444B8 (da) |
| CA (1) | CA2713111C (da) |
| CO (1) | CO6230986A2 (da) |
| CY (1) | CY1114140T1 (da) |
| DK (1) | DK2235002T3 (da) |
| EA (1) | EA017736B1 (da) |
| ES (1) | ES2398335T3 (da) |
| HR (1) | HRP20130040T1 (da) |
| IL (1) | IL207212A (da) |
| NZ (1) | NZ586630A (da) |
| PL (1) | PL2235002T3 (da) |
| PT (1) | PT2235002E (da) |
| SI (1) | SI2235002T1 (da) |
| WO (1) | WO2009094417A1 (da) |
| ZA (1) | ZA201005248B (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009303602B2 (en) | 2008-10-14 | 2012-06-14 | Sunshine Lake Pharma Co., Ltd. | Compounds and methods of use |
| KR20110133048A (ko) | 2009-03-21 | 2011-12-09 | 닝 시 | 아미노 에스테르 유도체, 그의 염 및 이용 방법 |
| CA2800998A1 (en) * | 2010-04-29 | 2011-11-10 | Deciphera Pharmaceuticals, Llc | Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| RU2477723C2 (ru) | 2011-06-16 | 2013-03-20 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
| EP2810937B1 (en) | 2012-01-31 | 2016-11-30 | Daiichi Sankyo Company, Limited | Pyridone derivative |
| MX2015001424A (es) | 2012-07-28 | 2016-03-09 | Calitor Sciences Llc | Compuestos pirazolona sustituidos y metodos de uso. |
| US8975282B2 (en) | 2012-07-28 | 2015-03-10 | Sunshine Lake Pharma Co., Ltd. | Substituted pyrazolone compounds and methods of use |
| US20140057926A1 (en) * | 2012-08-23 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| US9102624B2 (en) | 2012-08-23 | 2015-08-11 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| US20140057920A1 (en) * | 2012-08-23 | 2014-02-27 | Boehringer Ingelheim International Gmbh | Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| TWI690525B (zh) | 2014-07-07 | 2020-04-11 | 日商第一三共股份有限公司 | 具有四氫吡喃基甲基之吡啶酮衍生物及其用途 |
| CN105153026B (zh) * | 2015-08-21 | 2018-02-02 | 江西科技师范大学 | 含联芳基酰胺结构的索拉非尼衍生物及其制备方法和应用 |
| CA3125559A1 (en) * | 2019-01-03 | 2020-07-09 | Array Biopharma Inc. | Quinoline compounds as inhibitors of tam and met kinases |
| EP4332106A4 (en) * | 2021-06-22 | 2024-10-30 | LG Chem, Ltd. | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR |
| TWI822140B (zh) * | 2021-06-24 | 2023-11-11 | 南韓商Ｌｇ化學股份有限公司 | 作為ｒｏｎ抑制劑之新穎吡啶衍生物化合物 |
| WO2024067783A1 (zh) * | 2022-09-28 | 2024-04-04 | 上海济煜医药科技有限公司 | 含磷类化合物及其制备方法和医药应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0430885A3 (en) | 1989-12-01 | 1991-11-06 | Ciba-Geigy Ag | Anthelmintical compounds |
| WO1997017329A1 (en) | 1995-11-07 | 1997-05-15 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of growth factor receptor originating in platelet and pharmaceutical compositions containing the same |
| CA2333554A1 (en) | 1998-06-17 | 1999-12-23 | Chu-Baio Xue | Cyclic hydroxamic acids as metalloproteinase inhibitors |
| US6355660B1 (en) | 1999-07-20 | 2002-03-12 | Dow Agrosciences Llc | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| HUP0301764A3 (en) | 1999-07-20 | 2004-06-28 | Dow Agrosciences Llc | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| CN1391562A (zh) | 1999-09-21 | 2003-01-15 | 阿斯特拉曾尼卡有限公司 | 用作药物的喹唑啉衍生物 |
| JP2003528106A (ja) * | 2000-03-22 | 2003-09-24 | メルク フロスト カナダ アンド カンパニー | Ｐｔｐ−１ｂ阻害薬としての硫黄置換アリールジフルオロメチルホスホン酸類 |
| FR2812633A1 (fr) | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides |
| SE0102384D0 (sv) | 2001-07-03 | 2001-07-03 | Pharmacia Ab | New compounds |
| WO2003045921A1 (en) | 2001-11-28 | 2003-06-05 | Fujisawa Pharmaceutical Co., Ltd. | Heterocyclic amide compounds as apolipoprotein b inhibitors |
| SE0302487D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| JP2005263787A (ja) | 2004-02-17 | 2005-09-29 | Ishihara Sangyo Kaisha Ltd | アミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤 |
| US7459562B2 (en) * | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
| MXPA06012613A (es) | 2004-05-07 | 2007-01-31 | Amgen Inc | Derivados heterociclicos nitrogenados como moduladores de proteina cinasa y uso para el tratamiento de angiogenesis y cancer. |
| US7173031B2 (en) | 2004-06-28 | 2007-02-06 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
| US7432373B2 (en) | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| JO2787B1 (en) | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
| US7732613B2 (en) | 2005-09-14 | 2010-06-08 | Bristol-Myers Squibb Company | Met kinase inhibitors |
| US7880004B2 (en) | 2005-09-15 | 2011-02-01 | Bristol-Myers Squibb Company | Met kinase inhibitors |
| US7348325B2 (en) | 2005-11-30 | 2008-03-25 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| WO2009094427A1 (en) | 2008-01-23 | 2009-07-30 | Bristol-Myers Squibb Company | 4-pyridinone compounds and their use for cancer |
-
2009
- 2009-01-22 WO PCT/US2009/031649 patent/WO2009094417A1/en not_active Ceased
- 2009-01-22 KR KR1020107016439A patent/KR101596527B1/ko active Active
- 2009-01-22 PT PT97044572T patent/PT2235002E/pt unknown
- 2009-01-22 EA EA201001196A patent/EA017736B1/ru not_active IP Right Cessation
- 2009-01-22 SI SI200930516T patent/SI2235002T1/sl unknown
- 2009-01-22 BR BRPI0906444A patent/BRPI0906444B8/pt active IP Right Grant
- 2009-01-22 JP JP2010544403A patent/JP5314050B2/ja active Active
- 2009-01-22 ES ES09704457T patent/ES2398335T3/es active Active
- 2009-01-22 DK DK09704457.2T patent/DK2235002T3/da active
- 2009-01-22 AU AU2009206440A patent/AU2009206440B2/en active Active
- 2009-01-22 PL PL09704457T patent/PL2235002T3/pl unknown
- 2009-01-22 NZ NZ586630A patent/NZ586630A/en unknown
- 2009-01-22 CN CN200980110414.7A patent/CN101977906B/zh active Active
- 2009-01-22 US US12/863,697 patent/US8124768B2/en active Active
- 2009-01-22 EP EP09704457A patent/EP2235002B1/en active Active
- 2009-01-22 CA CA2713111A patent/CA2713111C/en active Active
- 2009-01-22 HR HRP20130040AT patent/HRP20130040T1/hr unknown
-
2010
- 2010-07-13 CO CO10085288A patent/CO6230986A2/es active IP Right Grant
- 2010-07-22 ZA ZA2010/05248A patent/ZA201005248B/en unknown
- 2010-07-25 IL IL207212A patent/IL207212A/en active IP Right Grant
-
2012
- 2012-01-12 US US13/349,173 patent/US8258118B2/en active Active
-
2013
- 2013-02-08 CY CY20131100116T patent/CY1114140T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2235002T3 (da) | 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer | |
| DK2342233T3 (da) | Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer | |
| DK2340042T3 (da) | Fremgangsmåder og præparater til behandling af cancer | |
| DK2483278T3 (da) | Benzoxazepin pi3k-inhibitorforbindelser og deres anvendelse i behandlingen af cancer | |
| DK2155188T3 (da) | Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft | |
| DK2185164T3 (da) | Sammensætning og terapeutisk antitumorvaccine | |
| DK2127652T3 (da) | Fremgangsmåde til behandling af cancer under anvendelse af anticancermiddel i kombination | |
| DK2473510T3 (da) | Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer | |
| DK2114419T3 (da) | Natriummetaarsenit til anvendelse i behandling af smerte og inflammation | |
| DK2365802T3 (da) | Mikrokapsler af rapamycin og anvendelse til behandling af cancer | |
| DK3517534T3 (da) | Forbindelser, der er anvendelige til behandling af cancer | |
| DK2101805T3 (da) | Integrinligander til anvendelse i behandling af cancer | |
| DK2356093T3 (da) | Carbazolforbindelser og terapeutiske anvendelser af forbindelserne | |
| DK2601962T3 (da) | Lag-3-doseringsskema til anvendelse i behandling af cancer | |
| DK3338790T3 (da) | Oligopeptid-forbindelser og anvendelser deraf | |
| DK2322221T3 (da) | Farmaceutisk sammensætning til behandling og forebyggelse af cancer | |
| BRPI0921321A2 (pt) | métodos para o tratamento de indwcções e tumores | |
| DK2121989T3 (da) | K-ras-mutationer og anti-EGFR-antistofbehandling | |
| BR112012004281A2 (pt) | uso de metformina tratamento e prevenção de câncer | |
| DK2170827T3 (da) | Indolin-2-oner og aza-indolin-2-oner | |
| DK2114447T3 (da) | Forebyggelse og behandling af subkliniks pcvd | |
| DK2001556T3 (da) | Thioninium-forbindelser og anvendelse deraf | |
| DK2200600T3 (da) | Neramexan til anvendelse ved behandlingen af subakut tinnitus | |
| DK2063881T3 (da) | Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer | |
| DK2536748T3 (da) | Neuregulin-antagonister og anvendelse deraf ved behandling af kræft |